ESPR Nov 2024 3.000 call
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 3.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.0700 - 0.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 30 |
GuruFocus.comMillennium Management LLC's Strategic Reduction in Esperion Therapeutics Inc Holdings
On September 30, 2024, Millennium Management LLC, a prominent hedge fund, made a significant adjustment to its investment portfolio by reducing its stake in Esperion Therapeutics Inc (NASDAQ:ESPR). This move is notable not only for its scale but also for the trading price of $1.65 per share, reflecting a strategic decision in the context of the firm's investment approach. Founded in 1989 by Israel Englander and Ronald Shear, Millennium Management LLC has evolved from a modest start-up with $35 million in seed money to a global hedge fund powerhouse.
Insider MonkeyIs Esperion Therapeutics, Inc. (ESPR) the Best NASDAQ Stock Under $5?
We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at where Esperion Therapeutics, Inc. (NASDAQ:ESPR) ranks among the best NASDAQ stocks under $5. Job Market Cools Yet Economists Remain Optimistic About Stability A Yahoo Finance report on September 28 reveals that consumers are beginning to feel […]
